Evert Schimmelpennink
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-01–present
-
Current
-
Contineum Therapeutics, Inc. (CTNM)
Proxy statement
Current -
2021-01-01–2026-05-07
-
2021-01-01–2026-05-07
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | LENZ Therapeutics, Inc. (LENZ) | President and Chief Executive Officer | $690,000 | $7,036,009 |
| 2024 | LENZ Therapeutics, Inc. (LENZ) | President and Chief Executive Officer | $607,125 | $6,983,510 |
| 2023 | LENZ Therapeutics, Inc. (LENZ) | President and Chief Executive Officer | $537,438 | $2,517,407 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.